The CNN followed a similar trend: 83% were labeled as CNV+ and were diagnosed with NV AMD, and 94% were labeled as CNV− and were diagnosed with NNV AMD; on the other hand, the CNN labeled only 24% of NV AMD patients as IRF/SRF+, while it labeled 99% of the NNV AMD patients as IRF/SRF− (results in Table 5). The gene discussed is SRF; the disease is age-related macular degeneration.